Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.

European Journal of Pharmacology
P C WongP B Timmermans

Abstract

DuP 753 (or EXP3174) and PD123177 are nonpeptide angiotensin (AII)-specific ligands, which show high affinities for two AII receptor subtypes, i.e. AT1 and AT2 sites, respectively. In furosemide-treated conscious dogs with high renin, DuP 753 and EXP3714, but not PD123177, were as effective as captopril in lowering blood pressure. Both DuP 753 and EXP3174 exhibited selective vascular antagonism of AII. In conscious dogs with normal renin, DuP 753, but not captopril or EXP3174, caused a dose-dependent but transient decrease in blood pressure. In anesthetized dogs, DuP 753 and captopril caused similar renal vasodilatation and natriuresis. The renal hemodynamic effects of DuP 753 and captopril were more pronounced in dogs with sodium depletion. These results suggest that the AT1 receptor mediates the pressor and renal effects of AII in dogs. The acute transient hypotensive effect of DuP 753 in normal-renin conscious dogs is probably unrelated to AII antagonism.

Citations

Jun 1, 1995·Clinical Cardiology·M Epstein
Nov 1, 1993·Journal of Clinical Pharmacology·R T EberhardtW H Frishman
Jun 11, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·D P BrooksM Gellai
Feb 14, 1995·European Journal of Pharmacology·J NaguraF Konno
Jul 4, 1995·European Journal of Pharmacology·K L ClarkG M Drew
Dec 4, 1995·European Journal of Pharmacology·T NakaharaK Nakayama
Nov 22, 1997·European Journal of Pharmacology·M ShibasakiI Yanagisawa
Jan 18, 2008·Journal of Human Hypertension·A PoduriM Khullar
Apr 1, 1995·British Journal of Pharmacology·K M StevensonE R Lumbers
Apr 25, 2014·Current Hypertension Reports·Gisele Maia EtelvinoRobson Augusto Souza Santos
Dec 1, 1994·Kidney International·M de Gasparo, N R Levens
Jul 5, 2005·Expert Opinion on Investigational Drugs·K DicksteinR Segal
Nov 1, 1995·Clinical and Experimental Hypertension : CHE·P C WongP B Timmermans
Jun 8, 2001·The Journal of International Medical Research·H SchierokW Wienen
Sep 26, 2001·Circulation·T Münzel, J F Keaney
Mar 15, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jens Lundbaek AndersenPeter Bie
Mar 9, 1999·Journal of Cardiovascular Pharmacology·B H LeeH S Shin
Feb 3, 2011·Annals of Medicine·Tommaso Gori, Thomas Münzel
Feb 12, 1998·The American Journal of Physiology·H C ChampionP J Kadowitz
May 3, 2001·Blood Pressure. Supplement·E Burgess
Jan 1, 1994·The Journal of Urology·D A GoldfarbA C Novick
Nov 13, 2010·Bioorganic & Medicinal Chemistry·Prashant NaikMange Ram Yadav

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.